AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact.The ...
LONDON (Reuters) -- AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided ...
AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...
AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...
AstraZeneca said on Thursday it has received a notice in China over unpaid taxes related to the import of two cancer therapies, as the drugmaker continues to gauge the impact of probes into certain ...
10h
Pharmaceutical Technology on MSNAstraZeneca’s shares rise as it addresses China investigationIn addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
Shares in drugs giant AstraZeneca (AZN) looked perkier today as it reported a rise in sales and eased investor fears over the ...
Failed to fetch dynamically imported module: https://sg.finance.yahoo.com/assets/_app/immutable/nodes/2.CFfDZYhZ.js ...
Astrazeneca's revenue jumped 21 per cent last year as the pharmaceutical recorded broad growth across its key businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results